Chemours reports Q4 2024 net loss of $8M, provides FY2025 EBITDA guidance of $825-975M

Chemours Co

2024-FY EPS reported $0.57 revenue$5,782,000,000

Q4 Net Sales $1.4B flat YoY; Net Loss $8M ($0.05 diluted) vs prior year loss $18M.
Q4 Adjusted Net Income $16M ($0.11) down from $46M ($0.31) prior year.
FY2024 Adj. EBITDA $786M, down from $1.0B; FY2025 outlook $825M-$975M.
Fully remediated four material weaknesses in internal control.
TSS segment Q4 record sales; Opteon Refrigerants up 23% YoY.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.